danhua shen

Mrs. danhua shen


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
XZXiaobo Zhang
Xiaobo Zhang
WBWei Ba
Wei Ba
XZXiaoya Zhao
Xiaoya Zhao
CWChen Wang
Chen Wang
QLQiting Li
Qiting Li
DSdanhua shen
danhua shen
The accurate pathological diagnosis of endometrial cancer (EC) improves the curative effect and reduces the mortality rate. Deep learning has demonstrated expert-level performance in pathological diagnosis of a variety of organ systems using whole-slide images (WSIs). It is urgent to build the deep learning system for endometrial cancer detection using WSIs. The deep learning model was trained and validated using a dataset of 601 WSIs from PUPH. The model performance was tested on three independent datasets containing a total of 1,190 WSIs. For the retrospective test, we evaluated the model performance on 581 WSIs from PUPH. In the prospective study, 317 consecutive WSIs from PUPH were collected from April 2022 to May 2022. To further evaluate the generalizability of the model, 292 WSIs were gathered from PLAHG as part of the external test set. The predictions were thoroughly analyzed by expert pathologists. The model achieved an area under the receiver operating characteristic curve (AUC), sensitivity, and specificity of 0.928, 0.924, and 0.801, respectively, on 1,190 WSIs in classifying EC and non-EC. On the retrospective dataset from PUPH/PLAGH, the model achieved an AUC, sensitivity, and specificity of 0.948/0.971, 0.928/0.947, and 0.80/0.938, respectively. On the prospective dataset, the AUC, sensitivity, and specificity were, in order, 0.933, 0.934, and 0.837. Falsely predicted results were analyzed to further improve the pathologists’ confidence in the model. The deep learning model achieved a high degree of accuracy in identifying EC using WSIs. By pre-screening the suspicious EC regions, it would serve as an assisted diagnostic tool to improve working efficiency for pathologists.

19 December 2022 in Pathology - Research and Practice
Verified
Journal Article
Closed access
XZXiaobo Zhang
Xiaobo Zhang
DCDeyi Chen
Deyi Chen
XZXiaoya Zhao
Xiaoya Zhao
CWChen Wang
Chen Wang
YHYijiao He
Yijiao He
DSdanhua shen
danhua shen

16 December 2022 in Oncology Letters
Verified
Journal Article
Open access
PDF file
XZXiaobo Zhang
Xiaobo Zhang
XZXiaoya Zhao
Xiaoya Zhao
CWChen Wang
Chen Wang
SLShanshan Lu
Shanshan Lu
YWYiqin Wang
Yiqin Wang
DSdanhua shen
danhua shen
The incidence of endometrial endometrioid carcinoma (EEC) has been gradually increasing over the past decade. Fertility‑sparing therapy with progestin is a treatment option for EEC or endometrial atypical hyperplasia (AH). The present study evaluated the role of numerous prognostic factors following fertility‑sparing therapy for EEC or AH. Furthermore, the present study assessed the strength of various clinicopathological indicators for the prediction of treatment efficacy. A retrospective analysis was performed of patients with EEC and AH who received fertility‑sparing therapy between August 2013 and September 2021 at Peking University People's Hospital (Beijing, China). Endometrial specimens were obtained from each patient after 3 months of treatment and at the end of the fertility‑sparing therapy, before treatment efficacy and prognosis were evaluated using the χ2 test. Furthermore, the protein expression levels of EEC biomarkers, such as estrogen receptor (ER), progesterone receptor (PR), paired box 2 (PAX2), PTEN and p53 were assessed using immunohistochemistry. The overall complete response (CR) rate of fertility‑sparing treatment in the EEC group was 67.39% (31/46), whereas that in the AH group was 86.49% (32/37). The difference between the CR rates in the EEC and AH groups was statistically significant (P50% positive PR expression were demonstrated to have a higher CR rate compared with those with ≤50% positive PR expression in both the EEC and AH groups. Furthermore, the PAX2‑positive group tended to demonstrate higher CR rates compared with the PAX2‑negative group in the patients with EEC. In conclusion, these data suggested that fertility‑sparing therapy is effective for patients with EEC and AH who wish to remain fertile after treatment. Specifically, in the AH group, a higher proportion of patients achieved a CR whilst also achieving this more rapidly. Furthermore, PR was demonstrated to be a useful marker for the evaluation of EEC and AH.

4 November 2023 in Pathology - Research and Practice
Verified
Journal Article
Closed access
XZXiaobo Zhang
Xiaobo Zhang
CWChen Wang
Chen Wang
DSdanhua shen
danhua shen


9 June 2020 in Oncology Letters
Verified
Journal Article
Open access
PDF file
XZXiaobo Zhang
Xiaobo Zhang
YXYougui Xu
Yougui Xu
TMTianyu Meng
Tianyu Meng
DSdanhua shen
danhua shen
According to the 2014 World Health Organization Classification of Tumors of Female Reproductive Organs, patients with cervical intraepithelial neoplasia 2 (CIN2) have an equivocal diagnosis, but p16 is considered as the reference index for CIN2. Positive p16 expression in CIN2 is associated with high‑grade squamous intraepithelial lesions (HSIL), whereas p16 negative lesions are low‑grade squamous intraepithelial lesions. The purpose of the present study was to examine the clinical value of p16 and human papillomavirus (HPV) E6/E7 mRNA in the prognostication of patients with CIN2. From January 2013 to January 2016, 108 patients were diagnosed with CIN2 by biopsy and followed up at 6‑month intervals at Peking University People's Hospital (Beijing, China). The expression of HPV E6/E7 mRNA was detected by in situ hybridization, while the expression of p16 and Ki‑67 proteins was detected by immunohistochemistry. Of the 108 CIN2 cases, 20 progressed to HSIL/CIN3, 36 cases demonstrated persistence with CIN2 after the follow‑up and 52 cases achieved regression (≤CIN1). Of the p16‑positive 82 cases, 20 cases were detected to have progressed, whereas in the p16‑negative group, no progression was observed. There were statistically significant differences among the p16‑positive and negative groups (P<0.05). In the HPV E6/E7 mRNA‑positive 69 cases, 18 cases were detected to have progressed, whereas in the HPV E6/E7 mRNA‑negative 39 cases, progression was detected in only 2 cases. There were statistically significant differences among the HPV E6/E7 mRNA‑positive and negative groups (P<0.05). The area under the receiver operating characteristics curve was plotted; the area under the curve for HPV E6/E7 mRNA was 0.745, that for p16 was 0.546 and that for Ki‑67 was 0.501. The detection of HPV E6/E7 mRNA may provide important predictive information for the prognosis of CIN2, however p16 and Ki‑67 proteins may provide little value.